Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Benfenati

Showing results (101-110 of 167) with videos related to

Pageof 17
Sort By:
The Journal of Biological Chemistry|November 15, 1993
Study of the conformation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, by fluorescence spectroscopyP Neyroz, F Desdouits, F Benfenati, et al.
The Biochemical Journal|February 15, 2001
Identification of synapsin I peptides that insert into lipid membranesJ J Cheetham, S Hilfiker, F Benfenati, et al.
Neuroscience Letters|May 1, 1979
A study on the effects of interaction between naloxone and 2-Br-alpha-ergocryptine or clonidine on luteinizing hormone, follicle-stimulating hormone, prolactin and thyroid-stimulating hormone levels in normal man serumL F Agnati, F Benfenati, P Cortelli, et al.
Brain Research|April 12, 1991
Changes in striatal mu and delta opioid receptors after transient forebrain ischemia: a quantitative autoradiographic studyF Benfenati, E M Pich, M Zoli, et al.
Acta Physiologica Scandinavica|May 1, 1985
Further evidence for the existence of interactions between receptors for dopamine and neurotensin. Dopamine reduces the affinity and increases the number of [3H]-neurotensin binding sites in the subcortical limbic forebrain of the ratL F Agnati, K Fuxe, N Battistini, et al.
Neuroscience Letters|November 4, 1981
Possible mixed agonist--antagonist activity of D-sulpiride at dopamine receptor level in manF Benfenati, P Bernardi, P Cortelli, et al.
Acta Physiologica Scandinavica. Supplementum|January 1, 1984
Computer-assisted morphometry and microdensitometry of transmitter- identified neurons with special reference to the mesostriatal dopamine pathway. Methodological aspectsL F Agnati, K Fuxe, F Benfenati, et al.
Acta Physiologica Scandinavica|April 1, 1989
Neurotensin modulates the binding characteristics of dopamine D2 receptors in rat striatal membranes also following treatment with tolueneG von Euler, K Fuxe, F Benfenati, et al.
The European Journal of Neuroscience|December 1, 1996
Synapsin-like molecules in Aplysia punctata and Helix pomatia: identification and distribution in the nervous system and during the formation of synaptic contacts in vitroG Cibelli, M Ghirardi, F Onofri, et al.
Nature|October 1, 1992
Synaptic vesicle-associated Ca2+/calmodulin-dependent protein kinase II is a binding protein for synapsin IF Benfenati, F Valtorta, J L Rubenstein, et al.
Pageof 17

Showing results (101-110 of 167) with videos related to

Sort By:
Pageof 17
The Journal of Biological Chemistry|November 15, 1993
Study of the conformation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, by fluorescence spectroscopyP Neyroz, F Desdouits, F Benfenati, et al.
The Biochemical Journal|February 15, 2001
Identification of synapsin I peptides that insert into lipid membranesJ J Cheetham, S Hilfiker, F Benfenati, et al.
Neuroscience Letters|May 1, 1979
A study on the effects of interaction between naloxone and 2-Br-alpha-ergocryptine or clonidine on luteinizing hormone, follicle-stimulating hormone, prolactin and thyroid-stimulating hormone levels in normal man serumL F Agnati, F Benfenati, P Cortelli, et al.
Brain Research|April 12, 1991
Changes in striatal mu and delta opioid receptors after transient forebrain ischemia: a quantitative autoradiographic studyF Benfenati, E M Pich, M Zoli, et al.
Acta Physiologica Scandinavica|May 1, 1985
Further evidence for the existence of interactions between receptors for dopamine and neurotensin. Dopamine reduces the affinity and increases the number of [3H]-neurotensin binding sites in the subcortical limbic forebrain of the ratL F Agnati, K Fuxe, N Battistini, et al.
Neuroscience Letters|November 4, 1981
Possible mixed agonist--antagonist activity of D-sulpiride at dopamine receptor level in manF Benfenati, P Bernardi, P Cortelli, et al.
Acta Physiologica Scandinavica. Supplementum|January 1, 1984
Computer-assisted morphometry and microdensitometry of transmitter- identified neurons with special reference to the mesostriatal dopamine pathway. Methodological aspectsL F Agnati, K Fuxe, F Benfenati, et al.
Acta Physiologica Scandinavica|April 1, 1989
Neurotensin modulates the binding characteristics of dopamine D2 receptors in rat striatal membranes also following treatment with tolueneG von Euler, K Fuxe, F Benfenati, et al.
The European Journal of Neuroscience|December 1, 1996
Synapsin-like molecules in Aplysia punctata and Helix pomatia: identification and distribution in the nervous system and during the formation of synaptic contacts in vitroG Cibelli, M Ghirardi, F Onofri, et al.
Nature|October 1, 1992
Synaptic vesicle-associated Ca2+/calmodulin-dependent protein kinase II is a binding protein for synapsin IF Benfenati, F Valtorta, J L Rubenstein, et al.
Pageof 17